Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Patti

Showing results (1-10 of 375) with videos related to

Pageof 38
Sort By:
European Neurology|February 23, 2016
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 YearsFrancesco Patti
Patient Preference and Adherence|February 19, 2010
Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherenceFrancesco Patti
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2017
Standardised Frankincense extract: new possible therapeutic option for patients with relapsing-remitting multiple sclerosisFrancesco Patti
Neurodegenerative Disease Management|January 19, 2019
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studiesFrancesco Patti
Expert Opinion on Investigational Drugs|August 11, 2012
Treatment of cognitive impairment in patients with multiple sclerosisFrancesco Patti
Neurology|September 9, 2016
Hormone replacement in menopausal women with multiple sclerosis: Looking back, thinking forwardRhonda Voskuhl, Francesco Patti
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumabFrancesco Patti, Angelo Pappalardo
Neurology|July 1, 2016
US health insurance is an obstacle to disease-modifying treatments in MSDennis Bourdette, Francesco Patti
Multiple Sclerosis International|March 4, 2014
Gray matters in multiple sclerosis: cognitive impairment and structural MRISilvia Messina, Francesco Patti
Neuroepidemiology|May 14, 2014
Symptoms, prevalence and impact of multiple sclerosis in younger patients: a multinational surveyFrancesco Patti, Carlos Vila
Pageof 38

Showing results (1-10 of 375) with videos related to

Sort By:
Pageof 38
European Neurology|February 23, 2016
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 YearsFrancesco Patti
Patient Preference and Adherence|February 19, 2010
Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherenceFrancesco Patti
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2017
Standardised Frankincense extract: new possible therapeutic option for patients with relapsing-remitting multiple sclerosisFrancesco Patti
Neurodegenerative Disease Management|January 19, 2019
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studiesFrancesco Patti
Expert Opinion on Investigational Drugs|August 11, 2012
Treatment of cognitive impairment in patients with multiple sclerosisFrancesco Patti
Neurology|September 9, 2016
Hormone replacement in menopausal women with multiple sclerosis: Looking back, thinking forwardRhonda Voskuhl, Francesco Patti
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumabFrancesco Patti, Angelo Pappalardo
Neurology|July 1, 2016
US health insurance is an obstacle to disease-modifying treatments in MSDennis Bourdette, Francesco Patti
Multiple Sclerosis International|March 4, 2014
Gray matters in multiple sclerosis: cognitive impairment and structural MRISilvia Messina, Francesco Patti
Neuroepidemiology|May 14, 2014
Symptoms, prevalence and impact of multiple sclerosis in younger patients: a multinational surveyFrancesco Patti, Carlos Vila
Pageof 38